Severe dengue infection unmasking drug‐induced liver injury: Successful management with N‐acetylcysteine
Open Access
- 10 March 2024
- journal article
- research article
- Published by Wiley in Clinical Case Reports
- Vol. 12 (3)
Abstract
Key Clinical Message: Clinicians in tuberculosis and dengue endemic regions should have heightened vigilance for drug‐induced liver injury (DILI) overlapping with active infections, enabling prompt recognition and life‐saving conservative management. Severe dengue and drug‐induced liver injury (DILI) are significant independent risk factors for acute liver failure. The co‐occurrence of these conditions significantly complicates clinical management. Here, we describe the case of a 21‐year‐old Nepali female who developed acute liver failure during antitubercular therapy (ATT). The patient, presenting with fever and nausea after 3 weeks of ATT, subsequently received a diagnosis of severe dengue. Laboratory evidence indicated markedly elevated transaminases (AST 4335 U/L, ALT 1958 U/L), total bilirubin (72 μmol/L), and INR (>5). Prompt discontinuation of first‐line ATT, initiation of a modified ATT regimen, and N‐acetylcysteine (NAC) infusion facilitated the patient's recovery after a week of intensive care. This case underscores the potential for synergistic hepatotoxicity in regions where multiple endemic illnesses coincide. Early recognition of DILI, cessation of offending agents, and comprehensive intensive care are crucial interventions. While the definitive efficacy of NAC remains under investigation, its timely administration in these complex cases warrants exploration for its potential lifesaving benefits.Keywords
This publication has 26 references indexed in Scilit:
- Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitisArchives of Disease in Childhood, 2021
- Neglected tropical diseases activities in Africa in the COVID-19 era: the need for a “hybrid” approach in COVID-endemic timesInfectious Diseases of Poverty, 2021
- Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysisBMC Infectious Diseases, 2021
- N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failureCochrane Database of Systematic Reviews, 2020
- Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, ChinaEuropean Journal of Hospital Pharmacy, 2020
- Acute liver failure and death predictors in patients with dengue-induced severe hepatitisWorld Journal of Gastroenterology, 2020
- Drug‐induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitalsInternal Medicine Journal, 2018
- Risk factors, perceptions and practices associated with Taenia solium cysticercosis and its control in the smallholder pig production systems in Uganda: a cross-sectional surveyBMC Infectious Diseases, 2017
- Incidence and Clinical Outcome of Acute Liver Failure Caused by Dengue in a Hospital for Tropical Diseases, ThailandThe American Journal of Tropical Medicine and Hygiene, 2016
- Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenzaBMC Infectious Diseases, 2015